{"id":"2021091332","sourceId":"marketwatch","sourceName":"MarketWatch","providerName":"Dow Jones","title":"Valneva shares dive after U.K. ends vaccine supply deal","publishedDate":"2021-09-13T04:15:00-05:00","body":[{"type":"p","contentObject":[{"type":"text","content":"\n  Shares of Valneva  dived by 35% as the company said the U.K. has terminated a coronavirus vaccine supply deal. Valneva said it is continuing its VLA2001 development plan, and said it \"strenuously\" denies it is in breach of its obligations under the supply agreement. Phase 3 results are expected to be available early in the fourth quarter, and the company believes that initial approval for VLA2001 could be granted in late 2021. It said will increase its efforts with other potential customers to ensure that its inactivated vaccine can be used in the fight against the pandemic. ","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"p","contentObject":[{"type":"text","content":"\n  -Steve Goldstein ","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"pre","contentObject":[{"type":"text","content":"\n ","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"p","contentObject":[{"type":"text","content":"\n  (END) Dow Jones Newswires","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"p","contentObject":[{"type":"text","content":"\n  09-13-21 0515ET","gated":false}],"gated":false},{"type":"text","content":"\n\nCopyright (c) 2021 Dow Jones & Company, Inc.","gated":false}]}